Also trades as: ZLD.AX (ASX) · $vol 0M
ZLDAF OTC
Zelira Therapeutics Limited
1W: +0.0%
1M: +0.0%
3M: -25.7%
YTD: -4.3%
1Y: -1.4%
3Y: -52.7%
5Y: -96.1%
$0.26
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$656
-99.3% ▼
Gross Profit
-$803K
-7907.7% ▼
Operating Income
-$4M
+33.4% ▲
Net Income
-$4M
+90.1% ▲
EPS (Diluted)
$-0.32
+90.1% ▲
EBITDA
-$4M
+88.6% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $663K | $2M | $301K | $95K | $656 |
| YoY Growth | +0.0% | +132.3% | -80.5% | -68.5% | -99.3% |
| Cost of Revenue | $702K | $7M | $4M | $85K | $804K |
| Gross Profit | -$39K | -$6M | -$3M | $10K | -$803K |
| Gross Margin | -5.9% | -371.0% | -1068.0% | 10.8% | -122400.2% |
| R&D Expenses | $2M | $1M | $1M | $3M | $3M |
| SG&A Expenses | $6M | $6M | $3M | $1M | $485K |
| Operating Expenses | $10M | $8M | $6M | $6M | $3M |
| Operating Income | -$10M | -$13M | -$7M | -$6M | -$4M |
| Operating Margin | -1455.1% | -870.7% | -2159.3% | -6253.9% | -602467.8% |
| Interest Expense | $43K | $54K | $77K | $739K | $407K |
| Income Before Tax | -$10M | -$14M | -$6M | -$38M | -$4M |
| Tax Expense | -$1M | -$1M | $0 | -$920K | $0 |
| Net Income | -$9M | -$12M | -$6M | -$37M | -$4M |
| Net Margin | -1288.8% | -775.4% | -1850.8% | -38513.0% | -553029.3% |
| EPS (Diluted) | $-1.29 | $-1.49 | $-0.55 | $-3.22 | $-0.32 |
| EBITDA | -$8M | -$12M | -$7M | -$36M | -$4M |
| Shares Outstanding | 7M | 8M | 10M | 11M | 11M |